Vical to Provide Company Update at the 2017 BIO International Convention

SAN DIEGO, June 15, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL) announced today that the company will provide an overview of its technologies, development programs, and outlook at 4:15 p.m. PT on Wednesday, June 21, at the BIO International Convention (San Diego, June 19 - 22). A webcast of the company’s presentation will be available live and archived through the Events & Presentations page in the Investors section of the Vical website at www.vical.com.

About VicalVical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at www.vical.com.

Contact: Andrew Hopkins
(858) 646-1127
Website:  www.vical.com

You May Also Be Interested In

• Phoenix Capital Group Acquires 1,500 Royalty Acres in Utah's Prolific Uinta Basin
• AM Best Maintains Under Review with Negative Implications Status for Credit Ratings of RF&G Insurance Company Limited
• MANN PACKING UNVEILS ®EAL MANN'S BROCCOLINI™ CAMPAIGN TO EDUCATE AND PROTECT TRADEMARK AMID GROWING POPULARITY